164 related articles for article (PubMed ID: 23741542)
1. Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage.
Larciprete G; Montagnoli C; Frigo M; Panetta V; Todde C; Zuppani B; Centonze C; Bompiani A; Malandrenis I; Cirese A; Valensise H
J Prenat Med; 2013 Jan; 7(1):12-8. PubMed ID: 23741542
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Carbetocin versus Oxytocin for the Prevention of Primary Post Partum Haemorrhage after Caesarean Section in Mymensingh Medical College Hospital, Bangladesh.
Hussain CF; Akter SN; Amin SE; Chowdhury UK; Choudhury MF; Zahan F
Mymensingh Med J; 2022 Jan; 31(1):72-79. PubMed ID: 34999683
[TBL] [Abstract][Full Text] [Related]
3. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
4. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
[TBL] [Abstract][Full Text] [Related]
5. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
6. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
7. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
[TBL] [Abstract][Full Text] [Related]
8. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.).
Whigham CA; Gorelik A; Loughnan TE; Trivedi A
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3866-9. PubMed ID: 26940081
[TBL] [Abstract][Full Text] [Related]
9. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
[TBL] [Abstract][Full Text] [Related]
10. The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section.
Pisani I; Tiralongo GM; Gagliardi G; Scala RL; Todde C; Frigo MG; Valensise H
Pregnancy Hypertens; 2012 Apr; 2(2):139-42. PubMed ID: 26105099
[TBL] [Abstract][Full Text] [Related]
11. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin agonists for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D
BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768
[TBL] [Abstract][Full Text] [Related]
14. Clinical and financial evaluation of carbetocin as postpartum haemorrhage prophylaxis at caesarean section: A retrospective cohort study.
Wohling J; Edge N; Pena-Leal D; Wang R; Mol BW; Dekker G
Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):501-507. PubMed ID: 30411314
[TBL] [Abstract][Full Text] [Related]
15. A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway.
Bekkenes M; Jørgensen MM; Flem Jacobsen A; Wang Fagerland M; Rakstad-Larsen H; Solberg OG; Aaberge L; Klingenberg O; Steinsvik T; Rosseland LA
F1000Res; 2021; 10():973. PubMed ID: 34745566
[No Abstract] [Full Text] [Related]
16. Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial.
Al Zubaidi S; Alhaidari T
J Perinat Med; 2022 Feb; 50(2):150-156. PubMed ID: 34535047
[TBL] [Abstract][Full Text] [Related]
17. Comparison of carbetocin and oxytocin infusions in reducing the requirement for additional uterotonics or procedures in women at increased risk of postpartum haemorrhage after Caesarean section.
Tse KY; Yu FNY; Leung KY
Hong Kong Med J; 2020 Oct; 26(5):382-389. PubMed ID: 33028723
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
[TBL] [Abstract][Full Text] [Related]
19. Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage.
De Bonis M; Torricelli M; Leoni L; Berti P; Ciani V; Puzzutiello R; Severi FM; Petraglia F
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):732-5. PubMed ID: 21761999
[TBL] [Abstract][Full Text] [Related]
20. Uterine atony prophylaxis with carbetocin versus oxytocin and the risk of major haemorrhage during caesarean section: A retrospective cohort study.
Terblanche NC; Sharman JE; Jones MA; Gregory K; Sturgess DJ
Anaesth Intensive Care; 2023 Jul; 51(4):288-295. PubMed ID: 37314041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
